Roche out-licenses lebrikizumab rights to Dermira

06:47 EDT 9 Aug 2017 | PMLIVE

Swiss drug maker stands to receive $80m upfront for the drug

Original Article: Roche out-licenses lebrikizumab rights to Dermira


More From BioPortfolio on "Roche out-licenses lebrikizumab rights to Dermira"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...